Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Diquafosol Sodium Eye Drops

Approval Number

国药准字H20234037

Company北京诺思兰德生物技术股份有限公司

Registration Date

August 8, 2023

Drug Information

Generic Name

地夸磷索钠滴眼液

Dosage Form

眼用制剂

Strength

3%（5ml：150mg）

Drug Type

化学药品

Registration Date

August 8, 2023

Company Information

Applicant Company

Company Name北京诺思兰德生物技术股份有限公司

Company Address

北京市海淀区上地开拓路5号A406室

Manufacturing Company

Company Name北京汇恩兰德制药有限公司

Company Address

北京市通州区靓丽五街3号院7号楼

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

地夸磷索钠滴眼液 - NMPA 批准文号 | MedPath